Literature DB >> 6817775

Tumour lysis as a factor affecting blood levels of CEA.

J B Quayle.   

Abstract

A hypothesis is proposed that tumour lysis may be an important factor affecting blood levels of CEA. This has been explored in an experimental study with a model tumour system, consisting of immune-deprived mice bearing human CEA-producing tumours. Using agents such as irradiation, chemotherapeutic drugs, diphtheria toxin and techniques such as cryosurgery, it has been shown that tumour lysis is important when it is both rapid and extensive. The extent to which this may occur in patients remains uncertain, except in rare instances of dramatic response of malignant disease to treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817775      PMCID: PMC2011095          DOI: 10.1038/bjc.1982.186

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells.

Authors:  B Drewinko; L Y Yand
Journal:  Exp Cell Res       Date:  1976-09       Impact factor: 3.905

2.  Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast.

Authors:  S K Carter
Journal:  Cancer Treat Rev       Date:  1976-09       Impact factor: 12.111

3.  Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer.

Authors:  A T Skarin; R Delwiche; N Zamcheck; J J Lokich; E Frei
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

4.  Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress.

Authors:  A M Steward; D Nixon; N Zamcheck; A Aisenberg
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

5.  Carcinoembryonic antigen in patients treated with radiation therapy for invasive squamous cell carcinoma of the uterine cervix.

Authors:  E Donaldson; J R Van Nagell; E G Wood; Q Pletsch; D M Goldenberg
Journal:  AJR Am J Roentgenol       Date:  1976-11       Impact factor: 3.959

6.  Usefulness of serial carcinoembryonic antigen (CEA) determinations in monitoring chemotherapy.

Authors:  V L Young; R Kashmiri; Z R Hazen; W R Meeker
Journal:  South Med J       Date:  1976-10       Impact factor: 0.954

7.  Chemotherapy of human tumors in T-lymphocyte-deficient mice.

Authors:  B C Mitchley; S A Clarke; T A Connors; S M Carter; A M Neville
Journal:  Cancer Treat Rep       Date:  1977 May-Jun

8.  Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs.

Authors:  S K Khoo; E V MacKay
Journal:  Br J Obstet Gynaecol       Date:  1976-10

9.  Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma.

Authors:  M Ravry; C G Moertel; A J Schutt; V L Go
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

10.  Carcinoembryonic antigen (CEA) in patients with breast cancer.

Authors:  N M Borthwick; D W Wilson; P A Bell
Journal:  Eur J Cancer       Date:  1977-02       Impact factor: 9.162

View more
  1 in total

1.  Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model.

Authors:  J B Quayle
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.